Breast cancer: a systemic or local disease?

Area of Science:

• Oncology
• Epidemiology
• Clinical Trials

Background:

• Long-standing debate exists on whether breast cancer is systemic or local at its onset.
• Randomized trials suggest locoregional therapy variations do not impact breast cancer mortality, supporting the systemic hypothesis.
• Breast cancer screening trials indicate a 30% reduction in mortality for postmenopausal women.

Purpose of the Study:

• To reconcile the apparent contradiction between screening trial results and the systemic hypothesis of breast cancer.
• To analyze how screening impacts breast cancer survival curves and mortality.
• To explore potential mechanisms behind screening benefits, such as early intervention or host immune response.

Main Methods:

• Analysis of data from breast cancer screening trials focusing on mortality reduction in postmenopausal women.
• Examination of breast cancer survival curves to assess the impact of screening on prognosis.
• Review of existing hypotheses regarding the systemic versus local nature of breast cancer at inception.

Main Results:

• Screening trials demonstrate a 30% reduction in breast cancer mortality among postmenopausal women.
• Screening alters survival curves by prolonging survival but does not lead to a plateau, suggesting cure is not guaranteed.
• The observed benefits of screening do not necessarily refute the systemic hypothesis of breast cancer.

Conclusions:

• Screening may prolong time to recurrence and death rather than eliminate the risk for a subset of patients.
• Potential benefits of screening could stem from reduced micrometastatic burden or earlier systemic therapy administration.
• Further long-term follow-up of screening trial participants is needed to fully understand breast cancer's natural history.